Updated June 27 at 1:27pm
Biotechnology
60 results total, viewing 51 - 60
Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental product to replace the heart’s mitral valve without open-heart surgery. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to monitor the heart and repair damaged valves. more
A biomedical engineering professor at the University of Rhode Island has received a $6 million National Science Foundation grant for research to show how the nervous system functions in health and disease. more
Biotechnology giant Amgen Inc. posted third- quarter earnings that topped analysts’ estimates, driven by higher drug sales, and raised its forecast for the year. more
Richard A. Andrews has been appointed chief operating officer at ProThera Biologics. more
Richard A. Andrews recently was appointed chief operating officer at ProThera Biologics in Providence, a company that is developing inter-alpha inhibitor proteins to treat severe inflammation associated with infection, trauma and disease. He discussed his new role at the company with Providence Business News, as well as his past experience. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during spinal surgeries and will take an equity stake of up to 15 percent in the company. Mazor’s stock surged. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6